PT Bundamedik Tbk

Jakarta Stock Exchange BMHS.JK

PT Bundamedik Tbk Cash and Short-Term Investments for the year ending December 31, 2023: USD 40.81 M

PT Bundamedik Tbk Cash and Short-Term Investments is USD 40.81 M for the year ending December 31, 2023, a 6.41% change year over year. Cash and short-term investments are the sum of cash and short-term investments, representing the company's liquid assets.

PT Bundamedik Tbk Cash and Short-Term Investments for the year ending December 31, 2022 was USD 38.35 M, a -31.34% change year over year.
PT Bundamedik Tbk Cash and Short-Term Investments for the year ending December 31, 2021 was USD 55.85 M, a 28.82% change year over year.
PT Bundamedik Tbk Cash and Short-Term Investments for the year ending December 31, 2020 was USD 43.36 M, a 564.24% change year over year.
PT Bundamedik Tbk Cash and Short-Term Investments for the year ending December 31, 2019 was USD 6.53 M, a -4.33% change year over year.

Key data

Date	Cash and Short-Term Investments	Receivables	Inventory	Goodwill

Jakarta Stock Exchange: BMHS.JK

PT Bundamedik Tbk

CEO	Mr. Agus Heru Darjono
IPO Date	July 6, 2021
Location	Indonesia
Headquarters	Jl. Teuku Cik Ditiro No.28
Employees	1,434
Sector	Healthcare
Industries Pharmaceuticals Biotechnology Cosmetics Dental Care Drugstores & Retail Pharmacies Hospitals & Clinics Medical Instruments Personal Care

Description

PT Bundamedik Tbk provides health care services in Indonesia. As of December 31, 2021, the company operated 2 maternal and child hospitals, 3 general hospitals, 2 clinics, 10 IVF clinics, and 14 diagnostic laboratories. It also engages in the distribution of drugs, pharmaceuticals, and medical devices; and hotel, medical tourism, and management consulting businesses. The company was founded in 1973 and is headquartered in Jakarta Pusat, Indonesia. PT Bunda Medik is a subsidiary of PT Bunda Investama Indonesia.

Key trends

Past 5 years